Thöne, P.; Egger, M.; Geroldinger-Simic, M.; Kindermann, H.; Kocik, L.; Karasek, N.; Fischerlehner, B.; Spiegl, K.; Gruber, G.; Aschacher, B.;
et al. Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation. Vaccines 2024, 12, 275.
https://doi.org/10.3390/vaccines12030275
AMA Style
Thöne P, Egger M, Geroldinger-Simic M, Kindermann H, Kocik L, Karasek N, Fischerlehner B, Spiegl K, Gruber G, Aschacher B,
et al. Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation. Vaccines. 2024; 12(3):275.
https://doi.org/10.3390/vaccines12030275
Chicago/Turabian Style
Thöne, Paul, Margot Egger, Marija Geroldinger-Simic, Harald Kindermann, Lukas Kocik, Nicola Karasek, Barbara Fischerlehner, Kurt Spiegl, Georg Gruber, Bernhard Aschacher,
and et al. 2024. "Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation" Vaccines 12, no. 3: 275.
https://doi.org/10.3390/vaccines12030275
APA Style
Thöne, P., Egger, M., Geroldinger-Simic, M., Kindermann, H., Kocik, L., Karasek, N., Fischerlehner, B., Spiegl, K., Gruber, G., Aschacher, B., Dieplinger, B., Clodi, M., & Geinitz, H.
(2024). Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation. Vaccines, 12(3), 275.
https://doi.org/10.3390/vaccines12030275
